News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
572,983 Results
Type
Article (51451)
Company Profile (155)
Press Release (521377)
Section
Business (158472)
Career Advice (2449)
Deals (29361)
Drug Delivery (113)
Drug Development (72605)
Employer Resources (153)
FDA (15955)
Job Trends (12683)
News (284038)
Policy (30770)
Tag
Academia (2651)
Alliances (40588)
Alzheimer's disease (1335)
Approvals (15875)
Artificial intelligence (146)
Bankruptcy (307)
Best Places to Work (9791)
Breast cancer (182)
Cancer (1340)
Cardiovascular disease (123)
Career advice (2049)
CAR-T (99)
Cell therapy (283)
Clinical research (57799)
Collaboration (449)
Compensation (256)
COVID-19 (2617)
C-suite (107)
Data (1320)
Diabetes (171)
Diagnostics (5539)
Drug pricing (104)
Earnings (59741)
Employer resources (140)
Events (82752)
Executive appointments (353)
FDA (16618)
Funding (389)
Gene therapy (209)
GLP-1 (676)
Government (3997)
Healthcare (16187)
Infectious disease (2713)
Inflammatory bowel disease (111)
Interviews (448)
IPO (14316)
Job creations (3277)
Job search strategy (1714)
Layoffs (458)
Legal (7199)
Lung cancer (201)
Lymphoma (98)
Manufacturing (201)
Medical device (11743)
Medtech (11746)
Mergers & acquisitions (15191)
Metabolic disorders (486)
Neuroscience (1660)
NextGen Class of 2024 (5451)
Non-profit (3840)
Northern California (1595)
Obesity (284)
Opinion (204)
Patents (116)
People (47125)
Phase I (17443)
Phase II (25122)
Phase III (20051)
Pipeline (515)
Postmarket research (2453)
Preclinical (7301)
Radiopharmaceuticals (217)
Rare diseases (270)
Real estate (4757)
Regulatory (21083)
Research institute (2466)
Resumes & cover letters (408)
Southern California (1326)
Startups (3067)
United States (13761)
Vaccines (644)
Weight loss (226)
Date
Today (128)
Last 7 days (559)
Last 30 days (2394)
Last 365 days (32860)
2024 (32443)
2023 (36657)
2022 (47135)
2021 (50802)
2020 (48218)
2019 (39445)
2018 (29896)
2017 (29648)
2016 (28242)
2015 (31159)
2014 (24672)
2013 (20661)
2012 (22026)
2011 (22381)
2010 (20542)
Location
Africa (741)
Arizona (152)
Asia (34160)
Australia (6068)
California (3476)
Canada (1149)
China (259)
Colorado (156)
Connecticut (177)
Europe (80948)
Florida (504)
Georgia (118)
Illinois (338)
Indiana (184)
Maryland (595)
Massachusetts (2725)
Michigan (132)
Minnesota (247)
New Jersey (1000)
New York (976)
North Carolina (736)
Northern California (1595)
Ohio (126)
Pennsylvania (828)
South America (1116)
Southern California (1326)
Texas (498)
Washington State (364)
572,983 Results for "northwestern memorial s bluhm cardiovascular institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Clinical research
Bayer’s Kidney Disease Drug Kerendia Reduces Cardiovascular Risk by 16%
Bayer’s Kerendia, at the center of a $3 billion sales forecast, reduced the risk of cardiovascular death and heart failure in a Phase III trial.
September 3, 2024
·
2 min read
·
Annalee Armstrong
BioMidwest
Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter (VISABL-AFL) IDE clinical trial, commenced with two procedures performed at the Cardiovascular Institute of South Paris (ICPS) (https://icps.fr).
June 25, 2024
·
2 min read
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
Inspira Technologies OXY B.H.N Ltd., a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, has announced the signing of a non-binding Letter of Intent with Northwestern Memorial Hospital in Chicago, Illinois.
January 2, 2024
·
4 min read
Business
Northwestern Medicine Taps Douglas R. Johnston, MD, to Lead Cardiac Surgery
Nationally recognized cardiothoracic surgeon, Douglas R. Johnston, MD, has been named surgical director of Northwestern Medicine’s Bluhm Cardiovascular Institute and chief of the division of cardiac surgery at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.
October 13, 2022
·
4 min read
Press Releases
ZOLL Enrolls First Patient in Groundbreaking SSCORE Commercial Registry at Minneapolis Heart Institute at Abbott Northwestern Hospital (Minneapolis, MN)
September 24, 2024
·
5 min read
News
Northwestern University Files Patent Infringement Lawsuit Against Moderna Over mRNA Vaccine Technologies
October 21, 2024
·
3 min read
Regulatory
Novo Secures EU Panel’s Backing for Cardiovascular Use of Wegovy
With Thursday’s positive opinion from the Committee for Medicinal Products for Human Use, the matter now heads to the European Commission which will have the final say on whether Wegovy’s label will be updated.
September 20, 2024
·
2 min read
·
Tristan Manalac
Lone Star Bio
Vizient examines pulsed field ablation, wearables for women’s cardiovascular health in latest Medical Device Tech Watch
Vizient, Inc. examines pulsed field ablation technologies for atrial fibrillation and the role wearable monitoring devices can play in women’s cardiovascular health in the latest Medical Device Tech Watch.
June 20, 2024
·
3 min read
Policy
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView™ Monitoring System
Terumo Cardiovascular, a global leader in cardiovascular surgery technologies, announced that the U.S. Food and Drug Administration has granted 510 clearance for the CDI OneView Monitoring System.
May 28, 2024
·
3 min read
Drug Development
Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose Escalation Clinical Study with Dose Expansion of Oral Triapine® in Combination with Temozolomide (TMZ) for Patients with Recurrent Glioblastoma
Nanopharmaceutics, Inc., a clinical-stage pharmaceutical development company, announced the initiation of a Phase I clinical study with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University “A Phase 1 Adaptive Dose Escalation With Dose Expansion Study of Triapine in Combination With Temozolomide for Patients With Recurrent Glioblastoma”.
May 14, 2024
·
3 min read
1 of 57,299
Next